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Cell proliferationKi-1/57 (HABP4) and CGI-55 (SERBP1) are regulatory proteins and paralogs with 40.7% amino acid sequence
identity and 67.4% similarity. Functionally, they have been implicated in the regulation of gene expression on
both the transcriptional and mRNA metabolism levels. A link with tumorigenesis is suggested, since both
paralogs show altered expression levels in tumor cells and the Ki-1/57 gene is found in a region of chromosome
9q that represents a haplotype for familiar colon cancer. However, the target genes regulated by Ki-1/57 and CGI-55
are unknown. Here, we analyzed the alterations of the global transcriptome proﬁle after Ki-1/57 or CGI-55
overexpression in HEK293T cells by DNA microchip technology. We were able to identify 363 or 190 down-
regulated and 50 or 27 up-regulated genes for Ki-1/57 and CGI-55, respectively, of which 20 were shared
between both proteins. Expression levels of selected genes were conﬁrmed by qRT-PCR both after protein
overexpression and siRNA knockdown. The majority of the genes with altered expression were associated
to proliferation, apoptosis and cell cycle control processes, prompting us to further explore these contexts
experimentally. We observed that overexpression of Ki-1/57 or CGI-55 results in reduced cell proliferation,
mainly due to a G1 phase arrest, whereas siRNA knockdown of CGI-55 caused an increase in proliferation. In
the case of Ki-1/57 overexpression, we found protection from apoptosis after treatment with the ER-stress
inducer thapsigargin. Together, our data give important new insights that may help to explain these proteins
putative involvement in tumorigenic events.
© 2014 Elsevier B.V. All rights reserved.AIRBP1, plasminogen activator
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rasil.1. Introduction
Ki-1/57 (also named HABP4) has been discovered as an intracellular
cross-reactant of the monoclonal antibody Ki-1, the ﬁrst to speciﬁcally
detect malignant cells in Hodgkin's lymphoma [1]. The protein CGI-55,
also named SERBP1 (or PAIRBP1), has been ﬁrst described as an RNA
binding protein involved in the regulation of PAI-1 mRNA stability, by
binding to itsmRNA3′UTR [2,3]. Ki-1/57 andCGI-55 share 40.7% identity
and67.4% similarity,which suggest that theymight be paralogs, possibly
with similar or redundant functions in humancells [4]. Yeast two-hybrid
system protein–protein interaction data were obtained [4–12] and
suggested that both are involved in multiple steps in gene expression
regulation, although their exact roles and possible gene targets in
human cells remain to be identiﬁed.
Although the relationship of Ki-1/57 with Hodgkin's disease is still
unknown, further indications for the involvement of these proteins in
tumorigenic processes have been reported in the literature. Familial
colon cancer risk-associated SNP haplotypes have been found in strong
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gene (referred as HABP4) [13]. Overexpression of CGI-55 has been
detected in ovarian cancer and was correlated with advanced tumor
stage [14]. Also, high expression levels of CGI-55 have been found in
human lung cancer tissues and in a human giant cell lung carcinoma
cell line with high metastatic potential [15]. Furthermore, analysis of
different metastatic sites in individuals with prostate cancer reported
altered gene expression of CGI-55 in lymph node, liver and bone
metastasis [16].
The protein partners identiﬁed for Ki-1/57 by yeast two-hybrid
assays are involved in different gene expression regulatory processes.
Many of them are directly or indirectly involved in transcriptional
regulation, such as the chromatin remodeling protein CHD3 [4] and
the transcription factors MEF2C and p53 [5,6]. Others are involved
in the regulation of pre-mRNA splicing (hnRNPQ and SFRS9 [7])
and translation (RACK1 [17], CIRP [18], FMRP and the ribosomal protein
RPL38 [19]).
The participation of Ki-1/57 in RNA metabolism has been further
conﬁrmed through its in vitro binding to U-rich RNA probes and its
ability tomediate pre-mRNA splicing and translation activities of reporter
genes in transfected cells [7]. Furthermore, Ki-1/57 could be found in the
largemolecular weight complexes of 43–48S translation pre-initiation in
sucrose gradient co-sedimentation experiments [8]. Together, the
interaction of Ki-1/57 with proteins involved in splicing, chromatin
remodeling, transcription and translation suggests that Ki-1/57 might
be involved in regulating integrated gene expression mechanisms [20].
The structural features of Ki-1/57 are also in agreement with this
apparent high promiscuity of protein–protein interaction partners.
Several biophysical methodologies have been approached to conﬁrm
that Ki-1/57 belongs to the growing list of eukaryotic intrinsically
disordered proteins [21]. The function of this kind of proteins includes
regulation of transcription and translation, cellular signal transduction
and other cellular processes that require high structural ﬂexibility to
allow speciﬁc binding to multiple partners [22]. Additionally, the lack of
structure of these proteins provides accessibility to post-translational
modiﬁcation at several sites [23], consistent with the fact that Ki-1/57
can be phosphorylated on serine/threonine residues by the protein
kinase C [9] andmethylated on arginines by the argininemethyltransfer-
ase PRMT1 [10].
The subcellular localization of Ki-1/57 reﬂects its involvement
with gene expression regulation processes as well. It is located in
the cytoplasm, the nuclear pores and the nucleus, where it can be
found in association with nucleoli and other smaller nuclear bodies
[24]. This subcellular distribution can depend on different stimuli,
as observed during cell treatment with the methylation inhibitor
Adox and the PKC pathway inducer PMA, which leads to a relocation
of Ki-1/57 to the cytoplasm [9]. In untreated cells, Ki-1/57 canpartially lo-
calize to nuclear speckles [7], a place for post-transcriptional splicing and
storage of splicing factors [20]. On the other hand, upon Adox treatment,
Ki-1/57 can relocalize to other dot-like substructures in the nucleus, such
as nucleoli, where ribosomal biogenesis and maturation take place, and
also GEMS and Cajal bodies, which are important sites for spliceosomal
andnon-spliceosomal snRNPbiogenesis,maturation and recycling [7,20].
CGI-55 alike localizes to cytoplasm and nucleus, where it can also be
observed in a punctuated fashion in the perinuclear region, the nucleoli
and p80-coilin-positive coiled bodies [11]. Additionally, CGI-55 has
been found in cytoplasmic stress granules (SGs) and processing bodies
(p-bodies) under stress conditions [25,26]. These substructures are
cytoplasmic storage sites for non-translatingmRNA, and their assembly
is dynamically related with the inhibition of the translation initiation
and the disassembly of polysomes [27,28].
Here, we set out to obtain additional functional information on these
proteins from global gene expression data. Cultured cells transiently
overexpressing Ki-1/57 or CGI-55 had their total mRNAs proﬁled by
Affymetrix microarray gene expression technology. This revealed that
the affected genes are mostly involved in cellular processes such asproliferation, apoptosis and cell cycle control. In further assays, we
observed that Ki-1/57 and CGI-55 overexpressing cells showed reduced
cell growth, mainly due to G1 phase arrest. Consistent with the alteration
in apoptosis related gene expression, we found that Ki-1/57 overexpres-
sion can protect cells from apoptosis under treatment with the ER-
stress inducer thapsigargin. Together, these data add new clues for the
functional role of Ki-1/57 and CGI-55 in human cells yielding important
information that contribute to explain their so far putative involvement
in tumorigenic events.2. Materials and methods
2.1. Plasmid constructs and siRNAs
Cloning of the complete cDNA encoding Ki-1/57 in fusion with the
N-terminal Flag tag into pcDNA6 (pcDNA6-ﬂag-Ki-1/57) has been
previously described [29]. The N-terminally FLAG-tagged CGI-55 con-
struct cloned into pcDNA6 Myc/His (Invitrogen) was kindly provided
by John L. Goodier (University of Pennsylvania School of Medicine).
Knockdown of Ki-1/57 and CGI-55 was performed using siRNA and
scrambled siRNA from Ambion® In Vivo. HABP4 siRNA #87, #88, and
#89 were tested for Ki-1/57 and SERBP1 siRNA #1, #2 and #3 for CGI-
55. Under the tested conditions HABP4 siRNA #89 (siRNA Ki-1/57)
and SERBP1 siRNA #3 (siRNA CGI-55) generated the lowest expression
level of Ki-1/57 and CGI-55, respectively, compared to control cells
(scrambled siRNA).2.2. Cell culture, transient transfection and siRNA transfection
HEK293T cells were cultivated in high-glucose Dulbecco's modiﬁed
Eagle's medium (DMEM, Sigma) supplemented with 1% penicillin
G-streptomycin (Invitrogen) and 10% heat-inactivated fetal bovine
serum (FBS, Invitrogen, South America) at 37 °C and 5% CO2. For
microarray experiments cells were transfected by using the calcium
phosphate method [7]. For MTS assay of Ki-1/57 and CGI-55 overex-
pressing cells, Lipofectamine Reagent (Invitrogen) was used according
to manufacturer's instructions. Transfection of cells for qRT-PCR, EdU
incorporation assay, cell cycle analysis and apoptosis assay were
performed with linear 25 kDa polyethylenimine (PEI, Polysciences).
Brieﬂy, cells growing in a 6-well plate were transfected with 3 μg DNA
and 10 μL PEI (1 mg/mL) per well. Or cells plated in 24-well plates
were transfected with 1 μg DNA and 3.3 μL PEI per well. For knock-
down experiments, siRNA transfections were performed with cells
growing in 6-well plates using linear 25 kDa polyethylenimine
(PEI, Polysciences) with a ﬁnal siRNA concentration of 50 nM
and 16 μL PEI (1 mg/mL). The transfection reagent was removed
after 16 h.2.3. Total RNA isolation and microarray analysis
Total RNA was extracted from cells using TRIzol® (Invitrogen)
according to the manufacturer's instructions and quantiﬁed by OD260 nm
measurements using Nanodrop® (Thermo Scientiﬁc). Isolation of mRNA
was performed with Oligotex mRNA mini Kit (Qiagen) following the
manufacturer's protocol. mRNA (1 μg) of control and overexpressing
Ki-1/57 or CGI-55 cells was used for microarray analysis on human
genomeU133 Plus 2.0 Gene Arrays (Affymetrix, Santa Clara, CA). Label-
ing and washing were performed according to the standard Affymetrix
protocol. The arrays were scanned using a GeneChip Scanner 3000
(Affymetrix). Data analysis and quality control were done using GCOS
(Gene Chip Operating Software version 1.4). Quantity normalization
and subsequent data processing were performed using ArrayAssist x.5
software package (Stratagene).
2946 F.C. Costa et al. / Biochimica et Biophysica Acta 1843 (2014) 2944–29562.4. Quantitative real-time RT-PCR (qRT-PCR)
Total RNA was extracted from cells using TRIzol® (Invitrogen) and
treated with DNAse I RNAse Free (Thermo Scientiﬁc). 5 μg RNA was
reverse transcribed using SuperScript® III Reverse Transcriptase
(Invitrogen) with oligo (dT)20 primers. qRT-PCR was performed with
a 7500 real-time PCR system (Applied Biosystems) with speciﬁc
primers (Supplementary Table 1). Each real-time RT-PCR reaction (in
20 μL) contained 2× SYBRGreen PCRMasterMix (Applied Biosystems),
primers and template cDNA (1/100 of the cDNA reaction). The cycling
conditions consisted of an initial, single step of 10min at 95 °C, followed
by 40 cycles of 15 s at 95 °C, and 1 min at 60 °C. PCR ampliﬁcations
were performed in triplicates for each sample. Gene expression levels
were quantiﬁed relative to the expression of β-actin endogenous
control, using an optimized comparative Ct (ΔΔCt) value method.
2.5. Western blot analysis
HEK293T cells were collected at indicated times after transfection
and lysed in lysis buffer (20 mM Tris–HCl, pH 7.5, 150 mM NaCl,
1.5 mMMgCl2, 0.5 mMDTT, 1% NP-40, 0.1% Triton X-100 and complete
protease inhibitor set, Roche). Subsequently, the lysatewas treatedwith
DNAse I (Promega) and RNAse A and cleared at 14.000 ×g at 4 °C for
20 min. Protein concentrations were determined using the BCA Protein
Assay Reagent Kit (Thermo Scientiﬁc). Proteins from total cell lysates
were separated by SDS-PAGE electrophoresis and transferred onto a
PVDF membrane. After blocking with 5% skim milk for 1 h, membranes
were hybridized with one of the following: monoclonal anti-FLAG M2
antibody (Sigma) or monoclonal anti-β-tubulin antibody (Abcam).
Afterwashingwith TBST,membraneswere incubatedwith a horseradish
peroxidase-conjugate secondary antibody and detection was performed
using theWestern Blotting Luminol Reagent kit (Santa Cruz Biotech-
nology), according to the manufacturer's recommendations.
2.6. In silico PPI analysis
The retrieved Ki-1/57 and CGI-55 interacting partners from yeast
two-hybrid screens, together with the up- and down-regulated genes
identiﬁed from overexpression of Ki-1/57 and CGI-55 microarrays
were integrated in interaction networks using the Integrated Interactome
System (IIS) platform, developed at the Brazilian Biosciences National
Laboratory, Brazil (http://www.lge.ibi.unicamp.br/lnbio/IIS/) [30]. The
enriched biological processes from the Gene Ontology (GO, http://
www.geneontology.org/) database were calculated in each network
using the hypergeometric distribution [30]. The enriched transcription
factors for the up- and down-regulated genes were retrieved using
the Enrichr software [31] and mapped in each network. The interaction
networks were visualized using Cytoscape 2.8.3 software [32].
2.7. Phylogenetic analysis
A phylogenetic hypothesis was inferred by Bayesian inference (BI)
using MrBayes v3.2.2 [33] to provide an evolutionary discussion about
the function of proteins encoded by the CGI-55 (SERBP1) and Ki-1/57
(HABP4) genes. First, sequence data from these proteins were
downloaded from the UniProt database (http://www.uniprot.org/). To
root the phylogenetic tree, the VIG protein encoded by vasa intronic
gene (vig) from Drosophila melanogaster was selected as an outgroup.
Sequences were aligned using MAFFT [34] and the alignment was
manually inspected, being subsequently trimmed using G-blocks [35].
The JTT + G model [36] was calculated by ProtTest 3.3 [37] as the
best-ﬁt amino acid substitutionmodel, according to AIC and BIC criteria.
The BI phylogenetic trees were calculated using the Bayesian Markov
Chain Monte Carlo (MCMC) method with 1 × 107 generations and a
sample frequency of 103, considering the JTT + G substitution model.
The parameter convergence was analyzed in TRACER v1.5.0 (http://beast.bio.ed.ac.uk/tracer), and the chain reached a stationary distribution
after 1 × 105 generations. Then, 1% of the generated trees was burned to
produce the consensus tree.
2.8. MTS cell proliferation assay
HEK293T cells were seeded in 96-well plates, cultured to 60–70%
conﬂuence and transfected with pcDNA6-ﬂag-Ki-1/57, pcDNA6-ﬂag-
CGI-55 or pcDNA6 (control). For knockdown experiments cells were
transfected with siRNA against Ki-1/57 (siRNA #89), siRNA against
CGI-55 (siRNA #3) or scrambled siRNA. 16 h following transfection
the medium was replaced with Dulbecco's modiﬁed Eagle's medium
for normal medium (10% FBS) or serum starvation (1% FBS). At
the indicated time, cell proliferation was tested using the MTS
assay (CellTiter 96® AQueous One Solution; Promega) according to
manufacturer's protocol.
2.9. EdU incorporation assay
Cells were seeded in 6-well plates, transfectedwith pcDNA6-ﬂag-Ki-
1/57, pcDNA6-ﬂag-CGI-55 or empty pcDNA6 and maintained under
standard conditions (10% serum) or under serum starvation (1%
serum). 24 or 48 h after transfection, cells were pulsed with EdU,
incubated for further 4 h and harvested by trypsinization (0.25%
trypsin, 0.53 mM EDTA). Cells were seeded on poly-L-lysine (Sigma)-
treated cover slips, ﬁxed with 4% paraformaldehyde and permeabilized
using 0.5% Triton X-100 for 20 min at room temperature. Incorporation
of EdU was observed by incubating ﬁxed cells with 2% BSA in PBS for
30 min and Alexaﬂuor 488 for a further 30 min under Cu(I)-catalyzed
click reaction conditions, as described by the manufacturer (Click-iT®
EdU Imaging Kits, Invitrogen). Cells were washed with PBS, and
mounted on slides using Vectashield with DAPI (Vector Laboratories)
for ﬂuorescent microscopy. Images were taken on Confocal Laser
Scanning Microscope Leica TCS SP8 (magniﬁcation ×100). Column
graph shows the percentage of EdU-positive cells compared to total
cells (±SE). Experiments were performed in duplicate biological experi-
ments. A minimum of 400 cells was counted for each replicate.
2.10. Cell cycle analysis
Cells were seeded in 6-well plates, transfectedwith pcDNA6-ﬂag-Ki-
1/57, pcDNA6-ﬂag-CGI-55 or pcDNA6 and maintained under normal
conditions (10% serum) or under serum starvation (no serum) before
analysis. Following 48 h after transfection, ﬂoating cells were collected
and then added to the attached cells that have been harvested by
trypsinization. Cells were washed twice with cold PBS, ﬁxed with
2 mL of ice-cold 70% ethanol in PBS and incubated at 4 °C overnight.
The pellets were collected by centrifugation and resuspended in PBS so-
lution containing 60 μg/mL of propidium iodide, 0.5% Triton X-100 and
250 μg/mL of RNAse A. After incubation for 30 min in the dark at 37 °C
followed by 30min incubation at 4 °C, cells were analyzed for DNA con-
tent using a FACS Canto II (BD Pharmingen) and FACS DIVA software.
The cell cycle distribution is shown as the percentage of cells containing
2n (G1 phase), 4n (G2 andM phases) and S phase judged by propidium
iodide staining. The experiment was performed in triplicate biological
experiments.
2.11. Apoptosis assays
HEK293T cells were cultured in 6-well plates to 60–70% conﬂuency,
and then transfected with pcDNA6-Flag-Ki-1/57, pcDNA6-Flag-CGI-55
or pcDNA6. 8 h after transfection, cellswere treatedwith 30 μMcisplatin,
3 μg/mL actinomycin D or 10 μM thapsigargin for 16 h. Cells were then
detached from plates with trypsin (0.25% trypsin, 0.53 mM EDTA),
combined with ﬂoating cells and stained with Annexin V-FITC and
propidium iodide (BD Pharmingen, San Diego, CA, USA) according
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II (BD Pharmingen) and analyzed by FACS DIVA software. Results
shown in bar graphs represent annexin V positive cells and include
early and late apoptosis.
2.12. Statistical analysis
Data are displayed asmean± standarddeviation (SD). Comparisons
were analyzed by Student's t-test and a p-value b 0.05 was considered
to indicate statistical signiﬁcance. A statistical association between the
frequency of transcription factors classes of genes modiﬁed by Ki-1/57,
CGI-55 and the whole human genome was tested, using two-sided
Fisher's exact test.
3. Results
3.1. Global gene expression analysis
The association of Ki-1/57 with proteins involved in regulatory
mechanisms of transcription, RNAmetabolism and translation regulation
suggests a possible function for this protein in the regulation of gene
expression. Looking for additional functional information, we performed
microarray global gene expression analysis of HEK293T cells transiently
overexpressing Ki-1/57 or CGI-55 (Fig. 1) by using Affymetrix microarray
technology (Fig. 2). With a cutoff of 2-fold compared to cells transfected
with an empty pcDNA6, the expression of 413 genes was altered by Ki-
1/57 overexpression, with 88% of them down-regulated (363 down and
50 up-regulated genes) (Fig. 2A, top panel).
Similarly, the RNA expression proﬁle of CGI-55 overexpression was
also investigated. We found that 217 genes had differential expression
and 90% of them were also down-regulated (190 down and 27 up-
regulated genes) (Fig. 2A, bottom panel). These results suggest that
the functional role of these proteins in gene regulation might be
predominantly repressive. Interestingly, we found that Ki-1/57 and CGI-
55 can alter at least 20 genes in common, with most of them beingFig. 1. Ki-1/57 and CGI-55 overexpression in HEK293T cells. HEK293T cells were seeded in 6-w
(B, D) and comparedwith control (pcDNA6). At indicated time points (24 h and 48 h after transf
for total protein extraction. Relative expression level of Ki-1/57 (A) and CGI-55 (B)was determin
to β-actin. Data in histograms representmeans (of triplicate experiments)± SD.Western blot of
antibody and comparing with cells transfected with pcDNA6 vector. The antibody anti-β-tubulinrepressed by both proteins (Fig. 2B). This observation along with the
amino acid sequence similarity and our previous yeast two-hybrid
protein–protein interaction data reinforces the hypothesis of paralogy
between these proteins [7].3.2. Ki-1/57 and CGI-55 are paralogs that arose by a genome duplication in
the baseline leading to the chordates
In the Pfam database, CGI-55 (SERBP1) and Ki-1/57 (HABP4)
proteins are classiﬁed in the HABP4 family of hyaluronan-binding pro-
teins (accession PF04774). This family includes proteins that have been
observed to bind in vitro to hyaluronan (a glucosaminoglycan) or that
are involved in the regulation of mRNA stability [38]. However, proteins
classiﬁed in this family present a diverse architecture of domains and
motifs, and it is not known whether these proteins share a common
function. The initial reports of a hyaluronan binding activity for Ki-157
(HABP4) could not be shown to be of in vivo relevance.
Among proteins of the HABP4 family, the VIG protein of
D. melanogaster shares signiﬁcant similarity with CGI-55 and Ki-1/57.
This protein is a component of the RISC complex, the RNA-induced
silencing complex [39], and was selected as an outgroup in the phyloge-
netic analysis. Here, the molecular evolution of CGI-55 and Ki-1/57
proteins was assessed by Bayesian inference. The phylogenetic tree
shows that these proteins are indeed paralogous as previously
hypothesized and possibly originated from a major genome duplication
event (Fig. 3) at the baseline leading to the chordates. The so-called
HABP4 domain has as a characteristic to be enriched in several positively
charged amino acids. This may be the explanation for the initial
described binding of the negative charged hyaluronan but also may
act as an RNA or nucleic acid binding module.
In addition, the analysis of the architecture of domains and motifs
shows that CGI-55 and Ki-1/57 proteins have a distinct composition of
glycine/arginine rich motifs (RGG ⁄ RXR) ﬂanking the HABP4 domain
(Fig. 3). These RGG⁄RXR motifs can be found mainly in proteins
involved in RNA processing and transcriptional regulation [7]. Furtherell plates, transfected 48 h later with pcDNA6-ﬂag-Ki-1/57 (A, C) and pcDNA6-ﬂag-CGI-55
ection), cells were collected and resuspended in Trizol® for RNA extraction or in RIPA buffer
ed by quantitative RT-PCR experiments. The relative amount of eachmRNAwas normalized
cells transfectedwith pcDNA6-ﬂag-Ki-1/57 (C) and pcDNA6-ﬂag-CGI-55 (D) using anti-ﬂag
was used as a loading control.
Fig. 2.Ki-1/57 and CGI-55overexpression changes globalmRNAproﬁles ofHEK293T cells. (A)Heatmaps showﬂag-CGI-55 andﬂag-Ki-1/57 transfected cellsmRNAproﬁle 48 h after trans-
fection. Each line represents a gene in one of the analyzed replicates with fold change N 2 and p b 0.05. Both down-regulated (green) and up-regulated (red) RNAs were identiﬁed.
(B) Common genes affected by Ki-1/57 and CGI-55. Gene names in green color represent down-regulated genes and, in red color, up-regulated genes. (C) Gene Ontology (GO) term
analysis was performed to identify biological processes annotated among Ki-1/57 and CGI-55 regulated genes. The depicted genes were selected based on the following GO
term annotation: apoptosis, cell cycle control and cell proliferation.
2948 F.C. Costa et al. / Biochimica et Biophysica Acta 1843 (2014) 2944–2956analysis of the sequence alignment shows that the CGI-55 protein
presents three insertions rich in polar residues in HABP4 domain that
differ from Ki-1/57 protein. Together, these ﬁndings can explain boththe common origin and the functional differences between CGI-55
(SERBP1) and Ki-1/57 (HABP4) proteins, observed in gene expression
analysis and in biological assays.
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Biological process analyses were performed using Gene Ontology
(GO) annotation to specify and identify pathways among target genes
after Ki-1/57 and CGI-55 overexpression. The analyzed genes were
involved in several biological processes (transcription regulation, RNA
splicing, translation), but most evidently they were related to life/
death cellular decision pathways such as apoptosis (9 genes for CGI-55
and 18 for Ki-1/57), cell proliferation (23 for CGI-55 and 24 for Ki-1/57)
and cell cycle (7 for CGI-55 and 8 for Ki-1/57) (Fig. 2C). In order to ﬁnd
out functional interconnections between themicroarray gene expression
and the previously obtained protein–protein interaction data [4–12] we
built up networks for Ki-1/57 and CGI-55. The top enriched GO biological
processes among the yeast two-hybrid partners (dark blue), the up-
regulated genes (red), the down-regulated genes (green) and theFig. 3. Evolutionary analysis of CGI-55 and Ki-1/57 amino acid sequences. Top: the majority-rul
protein sequences obtained from the UniProt database (http://www.uniprot.org/). Beside each
the best trees found by MrBayes are shown. Below: details of sequence alignments of the so-cabackground intermediary proteins (gray) are detailed by clustering
the proteins in the networks (Fig. 4A and B). In yellow, the enriched
transcription factors described in different databases [31] related to
the up and down-regulated genes identiﬁed by Ki-1/57 and CGI-55
microarrays (called here “enriched transcription factors”, Fig. 4) are
represented. The enriched transcription factorswere classiﬁed according
to Wingender et al. [40] and the frequency of each TF class was deter-
mined. We observed that the frequency of TF classes assigned to the
genes targeted by Ki-1/57 and CGI-55 was signiﬁcantly different from
the frequency found in the human genome, but not from each other
(Ki-1/57 vs. CGI-55) (Fig. S2). These TFs (yellow nodes in the networks)
are particularly related to the apoptotic process (Fig. 4A and B). Further-
more, transcriptional factors were targeted by Ki-1/57 (e.g. BCLAF1, Fos,
ADNP) and CGI-55 (e.g. PRDM1, TCF3, TBX1) overexpression on the
observed global gene expression panel.e consensus tree was obtained by Bayesian MCMC coalescent analysis of 26 HABP4 family
node, the posterior probability values (PP) (expressed in percentage) calculated by using
lled HABP4 domain (hyaluronan binding protein 4).
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processes altered by Ki-1/57 and CGI-55 overexpression is cell prolifera-
tion. Representative modiﬁed genes by Ki-1/57 overexpression includes
the repression of α-taxilin (TXLNA), a protein correlated with prolifera-
tive activity of hepatocellular carcinoma and the metastatic and invasive
potential of renal cell carcinoma [41,42], as well as PLAU, PDXK, NRG1,
also involved in promoting cell proliferation. CGI-55 overexpression
decreased expression of proliferative genes as well (GNB1 and CCL14).
Considering previous yeast two-hybrid assay results, in which we also
found proteins related to proliferation control, like MAPRE1 for Ki-1/57
and CUL3 for CGI-55, these data collectively pinpoint that both Ki-1/57
and CGI-55 are involved directly or indirectly in repressive mechanisms
of cellular proliferation control.
Ki-1/57 and CGI-55 overexpression also modiﬁed the expression
of genes involved in apoptosis. Ki-1/57 overexpression, for example,
repressed the expression of the apoptosis related genes GRK5, IL1B,
PEG10 and PPP3CC (Fig. 4A). More speciﬁcally, Ki-1/57 expression
leads to the repression of negative apoptosis regulators such as
MAP2K5, ADNP, ANXA4, as well as the positive regulator BCLAF1.
Moreover, Ki-1/57 expression increased the mRNA levels of HSP90B1,
an endoplasmic reticulum chaperone that protects against ER stress-
induced apoptosis [43]. These observations might suggest an involve-
ment of Ki-1/57 inmolecular decisionmechanisms of death or protection
against death during stress situations, such as ER stress, genotoxic or
chemotherapeutic agents.
In the same way, CGI-55 overexpression also affected apoptosis
related genes, such asHAND2, TNS4, speciﬁcally, the negative regulators
MAP2K5, PAK7 and FOXO1, and the positive regulators NCOA1 and
BCL2L11. These alterations of the expression of apoptosis related genes
are in agreement with previous protein–protein interaction data, as
both Ki-1/57 and CGI-55 interact with DAXX [6], a signaling protein
that binds speciﬁcally to the Fas death domain [44] and TOPORS, a
protein that mediates the p53 cellular response in DNA damage [45].
Ki-1/57 overexpression down-regulated Cyclin-dependent kinase
15 (CDK15), TCF3, MAPK12, INHBA, Cyclin-Y (CCNY), and up-regulated
Tubulin alpha-4A (TUBA4A) and LIN37, which are proteins associated
with cell cycle or cell division control [46–49]. CGI-55 overexpression
also led to the down-regulation of cell cycle control genes, such as
nuclear distribution protein NDEL1 and GORASP1 [50,51]. Protein–
protein interaction data also support the involvement in cell division
mechanisms, such as the case of UBE2I and YBX1 (Ki-1/57 interacting
protein) and KIAA0101 (CGI-55 interacting protein), all of them
involved in cell cycle control.
Interestingly, Ki-1/57 overexpression increased the expression of 50
genes, with 10 of them assigned as DNA histones. We speculate they
could be involved in chromatin compaction during the gene repression
process caused by Ki-1/57 overexpression. Besides, they may be
associated to other biological processes affected by Ki-1/57, like
cell cycle and apoptosis [52,53]. This could be the case of H2AX
(H2AFX), which is responsible for recruiting multiple proteins to
chromatin during DNA damage/repair response [54]. In addition,
Ki-1/57 overexpression seems to affect histone function through
down-regulating the histone-lysine N-methyltransferase (SETMAR),
which is responsible for methylation of lysine residues in histone
proteins [55].
All these observations together prompted us to validate speciﬁc
targets enriched in relevant biological processes and further investigateFig. 4. Interaction networks of Ki-1/57 and CGI-55 from previous yeast two-hybrid screening
enriched GO biological processes among the yeast two-hybrid partners (dark blue), the up-reg
(yellow) and the background intermediary proteins (gray) are depicted in the (A) Ki-1/57 and
with a circle layout. Clusterswere assigned only to selectedmost relevant enriched biological pr
data; proteins belonging to more than one biological process were assigned to clusters with the
with more speciﬁc annotation in GO database. The histone HIST1H1C was assigned to “Apopto
HIST2H2BE from the Ki-1/57 network were assigned to “Cell cycle”, according to the Reacto
proportional to their fold change (FC ≥ 2.0, p ≤ 0.05). The protein-protein interaction networkwhether the overexpression of Ki-1/57 and CGI-55 inﬂuences cell cycle,
proliferation and apoptosis under stress conditions.
3.4. Validation of the microarray data
To further validate the microarray data ﬁndings, we analyzed by
quantitative real-time PCR (qPCR) representative mRNAs involved in
highly enriched biological processes targeted by Ki-1/57 and CGI-55
overexpression. For comparison, the average fold change in gene ex-
pression levels, determined by microarray and qPCR analysis, was
log2 transformed and is shown in Fig. 5A and B. Wewere able to con-
ﬁrm genes involved in apoptosis (A), cell proliferation (P) and cell
cycle (CC) targeted by Ki-1/57 and CGI-55 overexpression. For
MAP2K5, a protein kinase that mediates a signal cascade involved in
growth factor-stimulated cell proliferation, microarray data had
shown a 5.4-fold and 3.13-fold reduction in expression, targeted by
Ki-1/57 and CGI-55, respectively. qPCR results show 3.6-fold reduction
for CGI-55. Comparable results were observed for other tested genes.
Although there was a variation in the fold change values determined
by these two methods, the expression trends were consistent.
Next, we further validated our microarray data by performing
knockdown experiments of Ki-1/57 and CGI-55 (Fig. 5C and D).
Optimization experiments have shown that a good down-regulation
of Ki-1/57 expression occurred at all time points after transfection
(Fig. 5C), whereas CGI-55 worked best only after 24 and 48 h, showing
signiﬁcant recovery after 72 h (Fig. 5D). Although we performed
expression analysis at all time points after knockdown,most test points
did not show signiﬁcant differences. The most signiﬁcant results were
obtained for 5 genes after 96 h knockdown of Ki-1/57 (Fig. 5E)
and after 48 h knockdown of CGI-55 (Fig. 5F). These results largely
conﬁrmed those of the overexpression, meaning that genes that were
up or down-regulated upon overexpression, had an inverted characteris-
tic upon knockdown. For example, CADM1was repressed by overexpres-
sion of Ki-1/57 (Fig. 5A) and, upon knockdown (Fig. 5E, 96 h), it was
found to be more expressed. On the other hand, the histone HIST1H2AB,
for example, was up-regulated when Ki-1/57 was overexpressed
(Fig. 5A), but was found to be repressed when Ki-1/57 was knocked
down (Fig. 5E).
3.5. Cell proliferation, cell cycle and apoptosis analysis
To evaluate cell viability, MTS assays were performed with cells
overexpressing ﬂag-tagged Ki-1/57 or CGI-55. The results suggested
that the overexpression of both proteins may lead to a signiﬁcant
reduction of cell growth either under normal or serum-deprived
conditions (Fig. 6A, B). We also analyzed the effect of knockdown
of Ki-1/57 and CGI-55 on HEK293T cell viability (Fig. 6C). No apparent
differences were observed for Ki-1/57 (data not shown), but indeed,
we found an increased viable cell number at 72 h of transfection with
CGI-55 siRNA, under 10% serum condition (Fig. 6C). Although knock
down experiments may not necessarily yield opposite results of
overexpression assays, at least for CGI-55 we were able to observe
such an effect (Fig. 6A, C).
The percentage of proliferating cells was also evaluated by
measuring the incorporation of EdU in dividing cells. In agreement
with cell viability experiments, the overexpression of Ki-1/57 and
CGI-55 led to a reduced percentage of EdU incorporation. This resultdata and altered gene expression revealed by microarrays. The selected most relevant
ulated genes (red), the down-regulated genes (green), the enriched transcription factors
(B) CGI-55 networks by clustering the proteins involved in each of the biological processes
ocesses containing at least one protein from the yeast two-hybrid screening ormicroarray
best enrichment p-values. More speciﬁc biological processes are shown only for proteins
sis”, and histones H2AFJ, HIST1H2AB, HIST1H2AC, HIST1H2AJ, HIST1H4A, HIST2H2AC and
me database. The nodes sizes of up- and down-regulated proteins/mRNAs are depicted
s were built using the IIS platform [30] and visualized using the Cytoscape software.
Fig. 5.Validation ofmicroarray data by quantitative RT-PCR after Ki-1/57 and CGI-55 overexpression or siRNA knockdown. Fold change ofmRNAof genes targeted by overexpression (48 h
after transfection) of Ki-1/57 (A) and CGI-55 (B) inmicroarrays and conﬁrmative quantitative RT-PCR experiments were Log2 transformed and blotted together for comparison. The relative
amount of eachmRNA testedwas normalizedwith β-actin. The speciﬁc primers are listed in Supplementary Table 1. Data in histograms aremeans (of triplicate experiments)± SD. A stands
for genes involved in apoptosis, P for cell proliferation and CC for cell cycle. (C, D) HEK293T cells were seeded in 6-well plates and transfected 24 h later with siRNA against Ki-1/57 (C) and
CGI-55 (D). A scrambled siRNAwas used as negative control upon the same conditions. At indicated time points (24, 48, 72 and 96 h after transfection), cellswere collected and resuspended
in Trizol® for RNA extraction. The expression levels of Ki-1/57 and CGI-55 geneswere determined by quantitative RT-PCR experiments. (E, F) Genes found to have different expression levels
in microarray experiments after Ki-1/57 and CGI-55 overexpression were analyzed in knockdown experiments (E) Ki-1/57 knockdown reverses the effects observed upon overexpression.
Genes down-regulated by Ki-1/57 overexpression were up-regulated upon knockdown, 96 h after transfection with siRNA. Histones (HIST1H2AB and HIST1H3A), that were up-regulated
after overexpression were down-regulated upon Ki-1/57 knockdown. (F) Genes found to be down-regulated by CGI-55 overexpressionwere up-regulated 48 h after siRNA CGI-55 transfec-
tion. The relative amount of each mRNA tested was normalized by β-actin. Data in histograms are means of triplicate experiments ± SD.
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the lack of interfering mitogenic factors present in the serum
(Fig. 6D).
We further determined the effects of Ki-1/57 and CGI-55 on cell
cycle progression (Fig. 6E). Under normal growth conditions (10%
serum), no signiﬁcant differences were observed. However, under
serumstarvation, a G1 phase arrestwas observed in cells overexpressing
either Ki-1/57 or CGI-55.
Given that cell proliferation, cell cycle progression and apoptosis
are tightly related processes and that both Ki-1/57 and CGI-55 affected
the expression of apoptosis related genes, we then also examined the
apoptosis response of Ki-1/57 and CGI-55 overexpressing cells to stress.
Under thapsigargin (an ER-stress inducer) treatment, Ki-1/57overexpressing cells exhibited diminished apoptosis when compared
to pcDNA-transfected control cells (Fig. 7A). CGI-55 overexpressing
cells had an increased apoptosis rate, however no signiﬁcant differences
were observed under the tested stress conditions (Fig. 7B).
4. Discussion
By using microarray global gene expression analysis, we identiﬁed
approximately 400 and 200 genes affected by Ki-1/57 and CGI-55
overexpression, respectively. These data along with protein–protein in-
teraction data previously obtained in our group were used to build up
enriched functional networks considering relevant top enriched GO bi-
ological processes regulated by Ki-1/57 and CGI-55. Many of the target
Fig. 6. Analysis of cell viability, proliferation and cell cycle. (A-C) MTS assay was performed to determine the effect of Ki-1/57 and CGI-55 overexpression or knock down on cellular via-
bility. (A, B) HEK293T were seeded in 96-well plates and transfected 48 h later with pcDNA6-ﬂag-Ki-1/57, pcDNA6-ﬂag-CGI-55 or empty pcDNA6 vector. After 16 h the medium was
substituted with medium containing 10% (10% Serum, A) or 1% fetal bovine serum (Serum Starvation, B). At indicated time points (24, 48, 72 and 96 h after changing media), MTS
assay was performed and results are represented as mean OD (±SD) of 4 repeats. (C) MTS assay of CGI-55 and Ki-1/57 knockdown cells. Cells were seeded in 96-well plates, transfected
24 h later with, siRNA for CGI-55, Ki-1/57 or the control scrambled siRNA. After 16 h themediumwas substitutedwithmedium containing 10% fetal bovine serum. At indicated time points
(24, 48, 72 and 96 h after changing media), MTS assay was performed and results are represented as mean OD 490 nm (±SD) of 3 repeats. (D) EdU incorporation assay. HEK293T were
seeded in 6-well plates and processed as described above. The percentage of EdU-positive cells at 24 or 48 h after transfection was obtained for two conditions, 10% or 1% serum
(Serum Starvation). More than 400 cells were counted for each condition. Each bar represents mean±SD of 2 independent experiments. *p b 0.01 (E) DNA ﬂow cytometry analysis of
cell cycle proﬁles inHEK293pcDNA6 (control),ﬂag-Ki-1/57 orﬂag-CGI-55 transfected cells. Cellswere seeded in6-well plates in triplicate, transfected and analyzed 48h later. After trans-
fection, mediumwas changed 24 h before analysis for medium containing 10% FBS ormediumwith no serum (Serum Starvation). Data are presented as percentage of cells distributed in
G1, S and G2/M cell cycle phase (mean). *p b 0.05 vs. pcDNA6 transfected cells.
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mRNA metabolism, a result consistent with the previously obtained
protein–protein interaction data (Fig. S1) [4–12]. Although the exact
mechanisms could not be pinpointed here, it is worth noting that
most of the genes targeted by Ki-1/57 and CGI-55 overexpression
were down-regulated (~90%), indicating that these proteins could act
predominantly as repressors of gene expression.Fig. 7. Apoptosis analysis of cells overexpressing Ki-1/57 and CGI-55 under stress conditions. HE
(A) and CGI-55 (B) and compared with control (pcDNA6). 8 h after the transfection cells we
completing 24 h after transfection. Cell apoptosis was analyzed with annexin V-FITC and PI s
times; each bar represents mean ±. S.D. *p b 0.01 (A) and *p b 0.05 (B) vs. pcDNA transfectedOf particular functional interest, a representative biological process
affected by Ki-1/57 and CGI-55 overexpression was involved in life/
death decisions. Genes involved in apoptosis, proliferation and cell
cycle control showed alteration in their expression levels in both
microarray data and qPCR analysis. Expression of mRNA encoding
GRK5, a kinase that interacts and phosphorylates p53 during the
regulation of apoptosis and G2/M-phase transition [56,57] wasK293T cells were seeded in 6-well plates, transfected 48 h later with pcDNA6-ﬂag-Ki-1/57
re treated with 3 μg/mL Actinomycin D, 30 μM Cisplatin or 10 μM thapsigargin for 16 h,
taining by ﬂow cytometry. Experiments were performed in triplicate and repeated two
cells.
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calcium binding protein that inhibits apoptotic signals by maintaining
calcium homeostasis in the ER [58] showed increased expression. The
expression of TCF3, an important transcription factor that regulates
cell proliferation and cell cycle regulatory genes [46], was a target for
CGI-55 overexpression. MTBP, a protein that interacts with MDM2 (a
negative regulator of p53) and has a crucial role in mitotic progression
and proliferation in a p53-independentmanner [59–61], is also affected
by CGI-55.
Considering these information,we sought to further conﬁrmwhether
Ki-1/57 and CGI-55 overexpression would affect cell life/death decisions.
We observed reduced proliferation for both proteins in MTS and EdU in-
corporation experiments, and in both cases, the reductionwas intensiﬁed
in cells maintainedwith 1% fetal bovine serum. The reduced proliferation
could be due to the arrest of cell cycle progression, since under serum
starvation, Ki-1/57 and CGI-55 overexpression induced G1 cell cycle
arrest. On the other hand, the overexpression of Ki-1/57 did not yield
any alterations in the number of apoptotic cells. CGI-55 overexpression,
in contrast, increased apoptosis under normal conditions. Despite the
sequence similarity between these proteins, it seems they have acquired
distinct functional properties during evolution. This seems to be con-
ﬁrmed by these proteins differences in the protein–protein interaction
proﬁle, the apoptosis data set and their distinct sets of target genes.
While the apoptosis genes down-regulated by CGI-55 were mostly
negative apoptotic regulators, Ki-1/57 targeted positive and negative
regulators, increasing or reducing their expression. This is in agreement
with the ﬁnding that CGI-55 overexpression promotes a higher apoptosis
rate because it causes a repression of negative regulators of apoptosis. In
the case of Ki-1/57 overexpression, an inhibitory effect on apoptosis
could only be seen after thapsigargin treatment, indicating that positive
and negative inﬂuences on apoptosis may be in balance under absence
of thapsigargin.
Ki-1/57 and CGI-55 have cytoplasmic and nuclear localizations,
where they can be frequently observed in dot-like structures or nuclear
bodies such as Cajal bodies, nuclear speckles and PML-nuclear bodies
(PML-NBs) [4,7,8,10,11,26,62]. These granules are nuclear substructures
that respond to basic physiological processes as well as various forms of
stress. PML-NBs for instance localize at theproximity of active transcrip-
tion sites directly regulating the function of several transcription factors
and responding to viral attack and genome instability, by abducting,
modifying or degrading different protein partners [63,64]. Considering
the localization in such granules and the panel of genes involved in
apoptosis thatwere up or down-regulated by Ki-1/57 and CGI-55 overex-
pression, we then speculated that these two proteins would play some
role in protecting cells against stress conditions. The overexpression of
Ki-1/57 seemed to reduce the amount of apoptotic cells during treatment
with different stress reagents, most signiﬁcantly thapsigargin. The same
was not observed in cells overexpressing CGI-55, which did not lead to
an increase of the cells sensibility to the stressing agents.
We would like to point out that post-translational modiﬁcations
are an additional important factor that adds further regulatory com-
plexity to apoptosis signaling. For example in rat ovarian granulosa cells,
CGI-55 and PGRMC1 form a receptor complex required for the anti-
apoptotic effects of progesterone and the response of PGRMC1 to proges-
terone functions depends on PGRMC1 sumoylation status [65]. Moreover,
small ubiquitin-like modiﬁer (SUMO) can post-translationally modify
PML and other PML-NB components. PML interacts with itself and other
proteins through sumoylation and SUMO-interacting motif SIMs [63]
and sumoylation of PML is required for the recruitment of components
of PML-NBs [66]. CGI-55 interacts with the SUMO activating enzyme
subunit 2, UBA2, and with the SUMO E3 ligases PIAS1 and −3 [11].
Moreover, a systematic study on SUMO modiﬁcations in response to
heat shock, identiﬁed CGI-55 as a SUMO substrate [67]. In addition,
CGI-55 and Ki-1/57 possess different predicted sumoylation sites
(data not shown). Therefore, the association of Ki-1/57 and CGI-55 to
PML-NBs would involve their SUMO modiﬁcation and might inﬂuencethe participation of these two proteins in apoptosis response, but likely
in a differential manner.
The inﬂuence of Ki-1/57 overexpression on histones should also be
pointed out. Whereas histone overregulation might in part explain the
overall repressive effect of Ki-1/57 overexpression, some gene loci are
found to be preferentially associated with PML-NBs, as histone gene
clusters [68,69]. Moreover, not only transcription factors are found in
PML-NBs, but also histone-modifying enzymes and other chromatin
regulators, suggesting a role for PML-NBs in chromatin regulation [64].
Therefore, we can speculate that the up-regulation of histone genes by
Ki-1/57 overexpression might be via PML-NBs. In this respect, DAXX, a
Ki-1/57 and CGI-55 interacting partner and component of PML-NB,
may regulate chromatin dynamics by binding to histone deacetylases
and chromatin remodeling proteins [70]. Moreover, Ki-1/57 overex-
pression down-regulated the histone-lysine N-methyltransferase
(SETMAR), responsible for methylation of lysine residues in histones, a
pivotal process for heterochromatin formation [55]. It is important to
highlight that some of the histones triggered by Ki-1/57 overexpression
are related to stress response, such as H2AX, which is responsible for
recruiting multiple proteins to chromatin during DNA damage/repair
response [54]. This reinforces the possible role of Ki-1/57 in regulating
gene expression in response to stress.
The enriched transcription factors from the functional networks of
targeted genes by Ki-1/57 and CGI-55 overexpression were classiﬁed
and the frequency of each TF class determined. We observed that the
frequency of TF classes of the genes targeted by Ki-1/57 and CGI-55
was signiﬁcantly different from the frequency found in the human
genome, but not from each other (Ki-1/57 vs. CGI-55) (Fig. S2). This
might implicate in Ki-1/57 and CGI-55 roles as corepressors of genes
regulated by speciﬁc classes of TFs. It is important to note the increased
frequency of the immunoglobulin fold class, which includes the p53
family TF, awell-established interacting partner of Ki-1/57 [10]. Together
with the amino acid sequence similarity, the expression regulation of
common genes identiﬁed by the microarray study and our previous
yeast two-hybrid protein-protein interaction data, the TF classes analysis
also strengthens the hypothesis of paralogy between these proteins [7].
Ki-1/57 and CGI-55 are RBPs that under stress conditions localize on
SGs and PBs [25–27] and almost 90% of genes regulated by them were
down-regulated, demonstrating a repressor activity. Many of the
genes targeted by Ki-1/57 and CGI-55 are associatedwith the regulation
of transcription andmRNAmetabolism, andwith cellular fate pathways,
as apoptosis, cell cycle and proliferation. We speculate that these two
proteins could act directly or indirectly via global repression of genes
involved in response to stress conditions, possibly involving cytoplasmic
and/or nuclear bodies, and may act on several different levels of gene
expression regulation: from transcriptional level, through transcriptional
factors or chromatin remodeling, via mRNA stability and splicing to
translation initiation.
The high structural ﬂexibility of intrinsically disordered proteins
allows the binding to multiple partners and access of post-translational
modiﬁcations at several sites. Post-translation modiﬁcation of RNA-
binding proteins is an energetically economical way to adapt to
stress conditions, without new protein synthesis, and allows rapid
and reversible protein regulation. Ki-1/57 and CGI-55 are both
methylated, phosphorylated and we speculate that they are also
sumoylated. This could determine their cellular localization and mode
of action in response to different stress conditions.
5. Conclusions
Ki-1/57 and CGI-55 are paralogous regulatory proteins and have
been functionally implicated in the regulation of gene expression on
both the transcriptional and mRNA metabolism levels. The preliminary
characterization of their protein interaction proﬁles, their complex
subcellular localization and post-transcriptional modiﬁcations together
with theﬁnding of altered expression of these proteins in diverse cancer
2955F.C. Costa et al. / Biochimica et Biophysica Acta 1843 (2014) 2944–2956cells had suggested that they may be involved in the process of
tumorigenesis. Furthermore, the gene for Ki-1/57 is found in a region
of a chromosomewhich contains only four genes and represents a haplo-
type for familiar colon cancer. Here, we characterized the alterations of
the global transcriptome proﬁle after Ki-1/57 or CGI-55 ectopic overex-
pression in HEK293 cells by DNA microchip technology and identiﬁed
363 or 190 down-regulated and 50 or 27 up-regulated genes for Ki-1/57
andCGI-55, respectively, ofwhich 20were shared betweenboth proteins.
This latter ﬁnding together with an evolutionary analysis, strongly
suggests that both proteins are paralogs, which originated through an
event of a whole genome duplication in the baseline of chordate
evolution. Furthermore, the great majority of the genes with altered
expression are associated to proliferation, apoptosis and cell cycle
control processes. In further experiments, we could observe that
overexpression of Ki-1/57 and CGI-55 results indeed in reduced cell
proliferation, mainly due to a G1 phase arrest. In the case of Ki-1/57 over-
expression, we found protection from apoptosis after treatment with the
ER-stress inducer thapsigargin. Our transcriptome data together with a
correlation of the published protein interactome data suggest that Ki-1/
57 and CGI-55 have many overlapping functions and furthermore that
they act mainly as repressors that affect the expression of genes involved
in proliferation and cell cycle as well as apoptosis regulation. Taken
together, our data provide important new insights that may help to
explain these protein putative involvements in tumorigenic events.
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